Ampliphi Biosciences Corp (APHB) SEC Filing 8-K Material Event for the period ending Friday, October 12, 2018

Ampliphi Biosciences Corp

CIK: 921114 Ticker: APHB

View differences made from one to another to evaluate Ampliphi Biosciences Corp's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Ampliphi Biosciences Corp.


Assess how Ampliphi Biosciences Corp's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Ampliphi Biosciences Corp's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: APHB
CIK: 921114
Form Type: 8-K Corporate News
Accession Number: 0001144204-18-054026
Submitted to the SEC: Tue Oct 16 2018 4:05:30 PM EST
Accepted by the SEC: Tue Oct 16 2018
Period: Friday, October 12, 2018
Industry: Biological Products No Disgnostic Substances
  1. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: